Back to Journals » Clinical Optometry » Volume 16

Effectiveness of Mp-3 Microperimetric Biofeedback Fixation Training for Low Vision Rehabilitation in Patients Treated with Corticosteroid IVT in Retinal Vein Occlusions [Letter]

Authors Triwiyanto T , Luthfiyah S 

Received 4 August 2024

Accepted for publication 28 August 2024

Published 29 August 2024 Volume 2024:16 Pages 221—222

DOI https://doi.org/10.2147/OPTO.S490077

Checked for plagiarism Yes

Editor who approved publication: Mr Simon Berry



T Triwiyanto,1 Sari Luthfiyah2

1Department of Medical Electronics Technology, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia; 2Department of Nursing, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia

Correspondence: T Triwiyanto, Department of Medical Electronics Technology, Poltekkes Kemenkes Surabaya, Jl. Pucang Jajar Timur No. 10, Surabaya, East Java, Indonesia, Tel +628155126883, Fax +6231-5025609, Email [email protected]; [email protected]


View the original paper by Dr Malvasi and colleagues


Dear editor

I am writing to provide a comprehensive analysis of the paper titled “Effectiveness of Mp-3 Microperimetric Biofeedback Fixation Training For Low Vision Rehabilitation in Patients Treated With Corticosteroid IVT in Retinal Vein Occlusions” authored by Mariaelena Malvasi et al published in Clinical Optometry.1 This study delves into the efficacy of Mp-3 Microperimetric Biofeedback Fixation Training in enhancing visual outcomes for individuals with retinal vein occlusions undergoing corticosteroid IVT treatment. The primary contribution of this research lies in its exploration of a novel approach, Mp-3 Microperimetric Biofeedback Fixation Training, as a means of low vision rehabilitation in patients with retinal vein occlusions. The findings presented in the study demonstrate promising results in improving visual acuity, central macular thickness, mean retinal sensitivity, and fixation stability over the course of the rehabilitation sessions. This highlights the potential of biofeedback training as a valuable adjunct therapy for individuals with occlusive retinal conditions undergoing corticosteroid IVT.

However, despite the significant contributions of this study, several critical limitations warrant consideration. Firstly, the duration of follow-up may not capture the long-term effects of Mp-3 Microperimetric Biofeedback Fixation Training.2 Furthermore, the lack of a control group hinders the ability to draw definitive conclusions regarding the efficacy of the intervention.3 Lastly, the absence of blinding in the assessment of outcomes introduces the potential for bias in the results.4 Moreover, in reviewing the methodology and results of the study, several errors come to light. Firstly, the selection criteria for the control eye in cases of bilateral involvement lack clarity, potentially introducing selection bias. Secondly, the description of the biofeedback training protocol could benefit from more detailed information on the specific parameters and techniques employed during the sessions. Additionally, the statistical analysis methods used to compare outcomes between time points could be further elaborated to enhance the transparency and reproducibility of the results. Lastly, the interpretation of changes in fixation stability could be strengthened by providing a more in-depth analysis of the underlying mechanisms driving these improvements.

Moving forward, it is recommended that future research endeavors in this area address the identified limitations by incorporating a larger and more diverse sample population, implementing longer follow-up periods to assess sustained benefits, including robust control groups for comparative analysis, and enhancing methodological transparency and rigor. Furthermore, exploring the potential synergistic effects of combining Mp-3 Microperimetric Biofeedback Fixation Training with other rehabilitation modalities could offer valuable insights into optimizing visual outcomes for individuals with retinal vein occlusions.

In conclusion, the study by Malvasi et al sheds light on the promising role of Mp-3 Microperimetric Biofeedback Fixation Training in low vision rehabilitation for patients with retinal vein occlusions. By addressing the critical limitations, rectifying methodological errors, and embracing future research directions, the field stands to benefit from enhanced understanding and improved therapeutic approaches for individuals with occlusive retinal conditions.

Data Sharing Statement

No datasets were generated or analysed during the current study.

Ethical Approval

As this submission is a Letter to the Editor and does not involve humans and animals, no ethical approval was required for this publication.

Consent for Publication

Consent for publication was given by all participants.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Disclosure

The authors declare no competing interests in this communication.

References

1. Malvasi M, Compagno S, Segnalini A, et al. Effectiveness of Mp-3 microperimetric biofeedback fixation training for low vision rehabilitation in patients treated with corticosteroid ivt in retinal vein occlusions. Clin Optom. 2024;16:131–142. doi:10.2147/OPTO.S460999

2. Qian T, Xu X, Liu X, et al. Efficacy of MP-3 microperimeter biofeedback fixation training for low vision rehabilitation in patients with maculopathy. BMC Ophthalmol. 2022;22(1):197. doi:10.1186/S12886-022-02419-6

3. Paulus JK, Dahabreh IJ, Balk EM, Avendano EE, Lau J, Ip S. Opportunities and challenges in using studies without a control group in comparative effectiveness reviews. Res Synth Methods. 2014;5(2):152–161. doi:10.1002/JRSM.1101

4. Hróbjartsson A, Emanuelsson F, Thomsen ASS, Hilden J, Brorson S. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. Int J Epidemiol. 2014;43(4):1272. doi:10.1093/IJE/DYU115

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.